MedPath
NMPA Approval

lingzhi capsule

国药准字Z33020704

September 3, 2024

Drug Information

灵芝胶囊

胶囊剂

每粒装0.27克

中药

September 3, 2024

Company Information

Applicant Company

浙江省丽水市龙泉市炉田工业园区科伦大道9号

Manufacturing Company

浙江省龙泉市炉田工业园区科伦大道9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

灵芝胶囊 - NMPA 批准文号 | MedPath